Clinical Trial Results:
An open-label single-arm treatment extension study to evaluate the long-term efficacy and safety of Oxabact® for patients with primary hyperoxaluria who completed study OC5-DB-02
Summary
|
|
EudraCT number |
2018-003576-12 |
Trial protocol |
DE GB ES BE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Oct 2021
|
First version publication date |
10 Oct 2021
|
Other versions |
|
Summary report(s) |
Abbreviated CSR for OC5-OL-02_Vs 1_Core report + signatures_17 Sept 2021 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.